Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin

Objective The aim of this study was to investigate whether the stimulation of monocytic cells with procalcitonin (PCT) results in the release of proinflammatory cytokines. The effects of intravenous immunoglobulin (IVIG) on the production of cytokines from the cells stimulated with PCT were also stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammation research 2012-06, Vol.61 (6), p.617-622
Hauptverfasser: Murakami, Kazuki, Suzuki, Chiaki, Fujii, Akihiro, Imada, Teruaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 622
container_issue 6
container_start_page 617
container_title Inflammation research
container_volume 61
creator Murakami, Kazuki
Suzuki, Chiaki
Fujii, Akihiro
Imada, Teruaki
description Objective The aim of this study was to investigate whether the stimulation of monocytic cells with procalcitonin (PCT) results in the release of proinflammatory cytokines. The effects of intravenous immunoglobulin (IVIG) on the production of cytokines from the cells stimulated with PCT were also studied. Materials and methods Cultured monocytic cells [THP-1 cells treated with phorbol myristate acetate or peripheral blood mononuclear cells (PBMCs)] were stimulated with PCT. The protein levels of proinflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and high mobility group box-1] in the culture supernatants were determined by ELISA kits. The concentration of PCT-specific IgG antibody in IVIG was measured using a specific ELISA. Results PCT induced the release of cytokines from THP-1 cells in a time- and dose-dependent manner. IVIG inhibited the release of cytokines from the cells stimulated with PCT. It was confirmed that IVIG also inhibited TNF-α release in the same dose range for PBMCs stimulated with PCT. The presence of PCT-specific IgG antibody was detected in the tested IVIG, which might be one of the mechanisms. Conclusions PCT induced the release of proinflammatory cytokines from THP-1 cells and PBMCs. The function of PCT was prevented by the presence of IVIG.
doi_str_mv 10.1007/s00011-012-0452-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1020840167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020840167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-71e79a8b6e981d4f65fafa87d8483962ce7d68405e2f9db916c29c35723cd78d3</originalsourceid><addsrcrecordid>eNqNkUtrFjEUhoMotlZ_gBsJuHEzmttMMkspXgqFbix0N-TLnGlTc6lJRvlW_vWe4asiguAq4ZznfU9OXkJecvaWM6bfVcYY5x3jomOqF515RI65Eqwbmbl6jHcmZCeNZEfkWa23SBthxFNyJITsleTmmPw8S63Y75DyWqmPcU35OuTdGnyidwWw0SotEMBWoHnBWvZpCTZG23LZU7dv-atPgOJEb9ZoE405ZSx7Rx2EUGltPq7BNpjpD99uNgtng_MtJ5-ekyeLDRVePJwn5PLjhy-nn7vzi09np-_PO6dY3zrNQY_W7AYYDZ_VMvSLXazRs1FGjoNwoOfBIApiGefdyAcnRid7LaSbtZnlCXlz8MXp31aobYq-bu-zCXD1Cb-KoZ4P-j9Qzntp-rFH9PVf6G1eS8JFNkqqQXOlkOIHypVca4Fluis-2rJHaNqCnA5BThjktAU5GdS8enBedxHm34pfySEgDkDFVrqG8ufof7neA334qxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1013467144</pqid></control><display><type>article</type><title>Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Murakami, Kazuki ; Suzuki, Chiaki ; Fujii, Akihiro ; Imada, Teruaki</creator><creatorcontrib>Murakami, Kazuki ; Suzuki, Chiaki ; Fujii, Akihiro ; Imada, Teruaki</creatorcontrib><description>Objective The aim of this study was to investigate whether the stimulation of monocytic cells with procalcitonin (PCT) results in the release of proinflammatory cytokines. The effects of intravenous immunoglobulin (IVIG) on the production of cytokines from the cells stimulated with PCT were also studied. Materials and methods Cultured monocytic cells [THP-1 cells treated with phorbol myristate acetate or peripheral blood mononuclear cells (PBMCs)] were stimulated with PCT. The protein levels of proinflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and high mobility group box-1] in the culture supernatants were determined by ELISA kits. The concentration of PCT-specific IgG antibody in IVIG was measured using a specific ELISA. Results PCT induced the release of cytokines from THP-1 cells in a time- and dose-dependent manner. IVIG inhibited the release of cytokines from the cells stimulated with PCT. It was confirmed that IVIG also inhibited TNF-α release in the same dose range for PBMCs stimulated with PCT. The presence of PCT-specific IgG antibody was detected in the tested IVIG, which might be one of the mechanisms. Conclusions PCT induced the release of proinflammatory cytokines from THP-1 cells and PBMCs. The function of PCT was prevented by the presence of IVIG.</description><identifier>ISSN: 1023-3830</identifier><identifier>EISSN: 1420-908X</identifier><identifier>DOI: 10.1007/s00011-012-0452-8</identifier><identifier>PMID: 22354318</identifier><language>eng</language><publisher>Basel: SP Birkhäuser Verlag Basel</publisher><subject>12-O-Tetradecanoylphorbol-13-acetate ; Adult ; Allergology ; Biomedical and Life Sciences ; Biomedicine ; Calcitonin - pharmacology ; Calcitonin Gene-Related Peptide ; Cell culture ; Cell Line ; Cells, Cultured ; Cytokines ; Cytokines - immunology ; Dermatology ; Enzyme-linked immunosorbent assay ; High mobility group proteins ; Humans ; Immunoglobulin G ; Immunoglobulins ; Immunoglobulins, Intravenous - pharmacology ; Immunologic Factors - pharmacology ; Immunology ; Inflammation ; Interleukin 6 ; Intravenous administration ; Leukocytes, Mononuclear - drug effects ; Leukocytes, Mononuclear - immunology ; Monocytes ; Neurology ; Original Research Paper ; Peripheral blood mononuclear cells ; Pharmacology/Toxicology ; procalcitonin ; Protein Precursors - pharmacology ; Rheumatology ; Tumor necrosis factor- alpha</subject><ispartof>Inflammation research, 2012-06, Vol.61 (6), p.617-622</ispartof><rights>Springer Basel AG 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-71e79a8b6e981d4f65fafa87d8483962ce7d68405e2f9db916c29c35723cd78d3</citedby><cites>FETCH-LOGICAL-c405t-71e79a8b6e981d4f65fafa87d8483962ce7d68405e2f9db916c29c35723cd78d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00011-012-0452-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00011-012-0452-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22354318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murakami, Kazuki</creatorcontrib><creatorcontrib>Suzuki, Chiaki</creatorcontrib><creatorcontrib>Fujii, Akihiro</creatorcontrib><creatorcontrib>Imada, Teruaki</creatorcontrib><title>Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin</title><title>Inflammation research</title><addtitle>Inflamm. Res</addtitle><addtitle>Inflamm Res</addtitle><description>Objective The aim of this study was to investigate whether the stimulation of monocytic cells with procalcitonin (PCT) results in the release of proinflammatory cytokines. The effects of intravenous immunoglobulin (IVIG) on the production of cytokines from the cells stimulated with PCT were also studied. Materials and methods Cultured monocytic cells [THP-1 cells treated with phorbol myristate acetate or peripheral blood mononuclear cells (PBMCs)] were stimulated with PCT. The protein levels of proinflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and high mobility group box-1] in the culture supernatants were determined by ELISA kits. The concentration of PCT-specific IgG antibody in IVIG was measured using a specific ELISA. Results PCT induced the release of cytokines from THP-1 cells in a time- and dose-dependent manner. IVIG inhibited the release of cytokines from the cells stimulated with PCT. It was confirmed that IVIG also inhibited TNF-α release in the same dose range for PBMCs stimulated with PCT. The presence of PCT-specific IgG antibody was detected in the tested IVIG, which might be one of the mechanisms. Conclusions PCT induced the release of proinflammatory cytokines from THP-1 cells and PBMCs. The function of PCT was prevented by the presence of IVIG.</description><subject>12-O-Tetradecanoylphorbol-13-acetate</subject><subject>Adult</subject><subject>Allergology</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Calcitonin - pharmacology</subject><subject>Calcitonin Gene-Related Peptide</subject><subject>Cell culture</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Cytokines</subject><subject>Cytokines - immunology</subject><subject>Dermatology</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>High mobility group proteins</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulins</subject><subject>Immunoglobulins, Intravenous - pharmacology</subject><subject>Immunologic Factors - pharmacology</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Intravenous administration</subject><subject>Leukocytes, Mononuclear - drug effects</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Monocytes</subject><subject>Neurology</subject><subject>Original Research Paper</subject><subject>Peripheral blood mononuclear cells</subject><subject>Pharmacology/Toxicology</subject><subject>procalcitonin</subject><subject>Protein Precursors - pharmacology</subject><subject>Rheumatology</subject><subject>Tumor necrosis factor- alpha</subject><issn>1023-3830</issn><issn>1420-908X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkUtrFjEUhoMotlZ_gBsJuHEzmttMMkspXgqFbix0N-TLnGlTc6lJRvlW_vWe4asiguAq4ZznfU9OXkJecvaWM6bfVcYY5x3jomOqF515RI65Eqwbmbl6jHcmZCeNZEfkWa23SBthxFNyJITsleTmmPw8S63Y75DyWqmPcU35OuTdGnyidwWw0SotEMBWoHnBWvZpCTZG23LZU7dv-atPgOJEb9ZoE405ZSx7Rx2EUGltPq7BNpjpD99uNgtng_MtJ5-ekyeLDRVePJwn5PLjhy-nn7vzi09np-_PO6dY3zrNQY_W7AYYDZ_VMvSLXazRs1FGjoNwoOfBIApiGefdyAcnRid7LaSbtZnlCXlz8MXp31aobYq-bu-zCXD1Cb-KoZ4P-j9Qzntp-rFH9PVf6G1eS8JFNkqqQXOlkOIHypVca4Fluis-2rJHaNqCnA5BThjktAU5GdS8enBedxHm34pfySEgDkDFVrqG8ufof7neA334qxg</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Murakami, Kazuki</creator><creator>Suzuki, Chiaki</creator><creator>Fujii, Akihiro</creator><creator>Imada, Teruaki</creator><general>SP Birkhäuser Verlag Basel</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin</title><author>Murakami, Kazuki ; Suzuki, Chiaki ; Fujii, Akihiro ; Imada, Teruaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-71e79a8b6e981d4f65fafa87d8483962ce7d68405e2f9db916c29c35723cd78d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>12-O-Tetradecanoylphorbol-13-acetate</topic><topic>Adult</topic><topic>Allergology</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Calcitonin - pharmacology</topic><topic>Calcitonin Gene-Related Peptide</topic><topic>Cell culture</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Cytokines</topic><topic>Cytokines - immunology</topic><topic>Dermatology</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>High mobility group proteins</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulins</topic><topic>Immunoglobulins, Intravenous - pharmacology</topic><topic>Immunologic Factors - pharmacology</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Intravenous administration</topic><topic>Leukocytes, Mononuclear - drug effects</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Monocytes</topic><topic>Neurology</topic><topic>Original Research Paper</topic><topic>Peripheral blood mononuclear cells</topic><topic>Pharmacology/Toxicology</topic><topic>procalcitonin</topic><topic>Protein Precursors - pharmacology</topic><topic>Rheumatology</topic><topic>Tumor necrosis factor- alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murakami, Kazuki</creatorcontrib><creatorcontrib>Suzuki, Chiaki</creatorcontrib><creatorcontrib>Fujii, Akihiro</creatorcontrib><creatorcontrib>Imada, Teruaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murakami, Kazuki</au><au>Suzuki, Chiaki</au><au>Fujii, Akihiro</au><au>Imada, Teruaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin</atitle><jtitle>Inflammation research</jtitle><stitle>Inflamm. Res</stitle><addtitle>Inflamm Res</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>61</volume><issue>6</issue><spage>617</spage><epage>622</epage><pages>617-622</pages><issn>1023-3830</issn><eissn>1420-908X</eissn><abstract>Objective The aim of this study was to investigate whether the stimulation of monocytic cells with procalcitonin (PCT) results in the release of proinflammatory cytokines. The effects of intravenous immunoglobulin (IVIG) on the production of cytokines from the cells stimulated with PCT were also studied. Materials and methods Cultured monocytic cells [THP-1 cells treated with phorbol myristate acetate or peripheral blood mononuclear cells (PBMCs)] were stimulated with PCT. The protein levels of proinflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and high mobility group box-1] in the culture supernatants were determined by ELISA kits. The concentration of PCT-specific IgG antibody in IVIG was measured using a specific ELISA. Results PCT induced the release of cytokines from THP-1 cells in a time- and dose-dependent manner. IVIG inhibited the release of cytokines from the cells stimulated with PCT. It was confirmed that IVIG also inhibited TNF-α release in the same dose range for PBMCs stimulated with PCT. The presence of PCT-specific IgG antibody was detected in the tested IVIG, which might be one of the mechanisms. Conclusions PCT induced the release of proinflammatory cytokines from THP-1 cells and PBMCs. The function of PCT was prevented by the presence of IVIG.</abstract><cop>Basel</cop><pub>SP Birkhäuser Verlag Basel</pub><pmid>22354318</pmid><doi>10.1007/s00011-012-0452-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1023-3830
ispartof Inflammation research, 2012-06, Vol.61 (6), p.617-622
issn 1023-3830
1420-908X
language eng
recordid cdi_proquest_miscellaneous_1020840167
source MEDLINE; SpringerLink Journals
subjects 12-O-Tetradecanoylphorbol-13-acetate
Adult
Allergology
Biomedical and Life Sciences
Biomedicine
Calcitonin - pharmacology
Calcitonin Gene-Related Peptide
Cell culture
Cell Line
Cells, Cultured
Cytokines
Cytokines - immunology
Dermatology
Enzyme-linked immunosorbent assay
High mobility group proteins
Humans
Immunoglobulin G
Immunoglobulins
Immunoglobulins, Intravenous - pharmacology
Immunologic Factors - pharmacology
Immunology
Inflammation
Interleukin 6
Intravenous administration
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - immunology
Monocytes
Neurology
Original Research Paper
Peripheral blood mononuclear cells
Pharmacology/Toxicology
procalcitonin
Protein Precursors - pharmacology
Rheumatology
Tumor necrosis factor- alpha
title Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A07%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin%20prevents%20release%20of%20proinflammatory%20cytokines%20in%20human%20monocytic%20cells%20stimulated%20with%20procalcitonin&rft.jtitle=Inflammation%20research&rft.au=Murakami,%20Kazuki&rft.date=2012-06-01&rft.volume=61&rft.issue=6&rft.spage=617&rft.epage=622&rft.pages=617-622&rft.issn=1023-3830&rft.eissn=1420-908X&rft_id=info:doi/10.1007/s00011-012-0452-8&rft_dat=%3Cproquest_cross%3E1020840167%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1013467144&rft_id=info:pmid/22354318&rfr_iscdi=true